CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		3,944,000
Beginning balance at Dec. 31, 2022	$ (2,066)	$ 0	$ 83,804	$ (85,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of warrants in connection with Credit Agreement amendment	4,060		4,060
Stock options exercised	1		1
Vesting of restricted stock units (in shares)		118,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(24,000)
Repurchases of restricted stock for payroll tax withholding	(355)		(355)
Stock-based compensation expense	7,034		7,034
Adjustment due to the rounding impact from the Reverse Stock Split in lieu of issuing fractional shares (in shares)		36,000
Net loss	$ (36,666)			(36,666)
Ending balance (in shares) at Dec. 31, 2023	4,072,713	4,074,000
Ending balance at Dec. 31, 2023	$ (27,992)	$ 0	94,544	(122,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)		45,000
Stock options exercised	211		211
Vesting of restricted stock units (in shares)		163,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(47,000)
Repurchases of restricted stock for payroll tax withholding	(613)		(613)
Stock-based compensation expense	5,759		5,759
Issuance of shares due to litigation settlement (in shares)		212,000
Issuance of shares due to litigation settlement	1,756		1,756
Net loss	$ (25,915)			(25,915)
Ending balance (in shares) at Dec. 31, 2024	4,446,540	4,447,000
Ending balance at Dec. 31, 2024	$ (46,794)	$ 0	$ 101,657	$ (148,451)